This study utilizes bibliometric analysis to investigate the research landscape of FAP-directed cancer theranostics, focusing ...

United Theranostics is a national leader in providing cutting-edge radiopharmaceutical therapy and advanced molecular imaging in a comfortable, patient-centric outpatient setting. The Company is ...

Diverse Applications: FAPI-based radiotracers have shown promising results in diagnosing various cancers, particularly gastrointestinal malignancies, and have potential applications in inflammatory ...

Integro Theranostics, a clinical-stage company dedicated to advancing surgical outcomes with the use of a unique and proprietary cancer imaging agent, is excited to announce their collaboration with ...

United Theranostics closed a $15 million senior debt facility with Old National Bank. The company will use proceeds from the facility to fund ...

Successful detection of brain metastases using RAD 101 (18F-Pivalate) in a novel multiparametric imaging methodology (PET-mpMRI) study across 22 patients.All brain metastases, regardless of whether th ...

In the ongoing battle against triple negative breast cancer, Vanderbilt researchers have uncovered a promising non-invasive ...

Wide-moat GE HealthCare, or GEHC, is a top three global leader in the medical imaging market. It has a firmly established footprint in hospitals and health networks around the world, and it is ...

The company’s RAD 101 imaging molecule identified brain tumours in all 12 treatment-naïve patients in a proof-of-concept ...

The addition of 177Lu-PSMA-617 to enzalutamide significantly improved overall survival and QOL in patients with metastatic ...

Apotex Inc. ("Apotex"), the largest Canadian-based pharmaceutical company, today announced a grant through the Apotex Global ...

France’s Framatome and IBA (Ion Beam Applications, Euronext), a specialist in particle accelerator technology and ...